Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedApr 15, 2026
DataAggregated Company Financials
Companies9
- 7D6.2%
- 3M-8.9%
- 1Y25.1%
- YTD0.9%
Over the last 7 days, the Pharma industry has risen 6.2%, driven by gains from Merck KGaA of 8.6%. In the last 12 months, the industry was up 25%. Looking forward, earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 15 Apr 2026 | €93.7b | €67.9b | -€883,899,020.69 | 19x | -106x | 1.4x |
| Fri, 13 Mar 2026 | €88.9b | €67.9b | -€900,290,891.88 | 18.6x | -98.7x | 1.3x |
| Sun, 08 Feb 2026 | €100.6b | €68.3b | €2.9b | 17.4x | 35.1x | 1.5x |
| Tue, 06 Jan 2026 | €93.8b | €68.3b | €2.9b | 17.9x | 32.7x | 1.4x |
| Thu, 04 Dec 2025 | €88.9b | €68.5b | €2.9b | 17.6x | 30.9x | 1.3x |
| Sat, 01 Nov 2025 | €78.9b | €68.8b | -€439,034,439.69 | 19.5x | -179.7x | 1.1x |
| Mon, 29 Sep 2025 | €76.1b | €68.8b | -€439,004,563.70 | 18.7x | -173.3x | 1.1x |
| Wed, 27 Aug 2025 | €78.1b | €68.9b | -€406,100,176.39 | 17.8x | -192.3x | 1.1x |
| Fri, 25 Jul 2025 | €80.4b | €69.4b | -€283,071,598.00 | 17.9x | -284x | 1.2x |
| Sun, 22 Jun 2025 | €76.6b | €69.4b | -€293,702,195.00 | 17.3x | -260.8x | 1.1x |
| Tue, 20 May 2025 | €75.0b | €69.4b | -€206,564,479.00 | 18x | -363.2x | 1.1x |
| Thu, 17 Apr 2025 | €74.8b | €69.3b | €467.0m | 18.1x | 160x | 1.1x |
| Sat, 15 Mar 2025 | €84.0b | €69.2b | €436.0m | 21.1x | 192.7x | 1.2x |
| Mon, 10 Feb 2025 | €84.2b | €69.2b | €2.0b | 22.6x | 41.6x | 1.2x |
| Wed, 08 Jan 2025 | €85.3b | €69.2b | €2.0b | 23.4x | 42.4x | 1.2x |
| Fri, 06 Dec 2024 | €82.5b | €69.2b | €2.0b | 21.7x | 40.7x | 1.2x |
| Sun, 03 Nov 2024 | €93.9b | €69.4b | €1.6b | 20.1x | 60.2x | 1.4x |
| Tue, 01 Oct 2024 | €100.9b | €69.4b | €1.5b | 24.4x | 68.5x | 1.5x |
| Thu, 29 Aug 2024 | €104.9b | €69.4b | €1.5b | 25.5x | 71.2x | 1.5x |
| Sat, 27 Jul 2024 | €98.8b | €69.2b | -€303,627,757.00 | 29.5x | -325.3x | 1.4x |
| Mon, 24 Jun 2024 | €100.6b | €69.2b | -€327,989,929.00 | 30.3x | -306.7x | 1.5x |
| Wed, 22 May 2024 | €102.4b | €69.2b | -€318,587,180.00 | 21.6x | -321.3x | 1.5x |
| Fri, 19 Apr 2024 | €91.9b | €70.0b | -€34,208,180.00 | 20.1x | -2685.9x | 1.3x |
| Sun, 17 Mar 2024 | €96.5b | €70.0b | €6.5m | 19.8x | 14855.7x | 1.4x |
| Tue, 13 Feb 2024 | €96.7b | €70.6b | -€650,504,143.00 | 20.1x | -148.6x | 1.4x |
| Thu, 11 Jan 2024 | €99.0b | €70.6b | -€650,504,143.00 | 20.1x | -152.2x | 1.4x |
| Sat, 09 Dec 2023 | €95.8b | €70.6b | -€650,606,256.00 | 18.2x | -147.2x | 1.4x |
| Mon, 06 Nov 2023 | €107.5b | €72.1b | €4.7b | 17.6x | 23x | 1.5x |
| Wed, 04 Oct 2023 | €113.9b | €72.1b | €4.7b | 19.8x | 24.4x | 1.6x |
| Fri, 01 Sep 2023 | €124.8b | €72.1b | €4.6b | 22x | 26.9x | 1.7x |
| Sun, 30 Jul 2023 | €124.2b | €74.1b | €6.5b | 17.3x | 19.3x | 1.7x |
| Tue, 27 Jun 2023 | €118.6b | €74.2b | €6.4b | 18.3x | 18.4x | 1.6x |
| Thu, 25 May 2023 | €127.4b | €74.0b | €6.4b | 22x | 20x | 1.7x |
| Sat, 22 Apr 2023 | €134.9b | €74.2b | €7.6b | 20x | 17.7x | 1.8x |
Price to Earnings Ratio
17.7x
Current Industry PE
- Investors are relatively neutral on the German Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 2.9% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 4.74% | |
| Healthcare | 5.86% | |
| Pharma | 6.17% | |
| Pharma | 6.17% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck KGaA | €117.55 | 4.1% +€2.0b | -0.9% | PE19.6x | |
| BAYN Bayer | €40.74 | 0.6% +€255.4m | 94.4% | PS0.9x | |
| DMP Dermapharm Holding | €45.50 | 8.7% +€196.5m | 22.3% | PE18.5x | |
| HIGH Cantourage Group | €5.08 | 8.1% +€4.7m | 11.6% | PS32.4x | |
| 27N0 Cannovum Cannabis | €0.39 | 14.7% +€115.6k | 109.1% | n/a |